Papp L Roy & Associates continued to hold its position in shares of Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,508 shares of the company’s stock at the close of the 2nd quarter. Papp L Roy & Associates’ holdings in Colgate-Palmolive were worth $2,039,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. TIAA CREF Investment Management LLC increased its holdings in Colgate-Palmolive by 84.2% in the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after buying an additional 2,082,262 shares during the last quarter. Swiss National Bank raised its stake in Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock valued at $268,393,000 after buying an additional 666,400 shares in the last quarter. Karp Capital Management Corp raised its stake in Colgate-Palmolive by 3,749.4% in the first quarter. Karp Capital Management Corp now owns 381,210 shares of the company’s stock valued at $27,901,000 after buying an additional 371,307 shares in the last quarter. Teachers Advisors LLC raised its stake in Colgate-Palmolive by 25.4% in the first quarter. Teachers Advisors LLC now owns 1,814,250 shares of the company’s stock valued at $132,785,000 after buying an additional 367,977 shares in the last quarter. Finally, Scopus Asset Management L.P. acquired a new stake in Colgate-Palmolive in the first quarter valued at $25,617,000. 73.10% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company (NYSE:CL) opened at 72.95 on Tuesday. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The stock has a market capitalization of $64.26 billion, a P/E ratio of 27.11 and a beta of 0.81. The firm’s 50-day moving average is $71.85 and its 200 day moving average is $73.19.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The firm’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.70 earnings per share. On average, equities analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.19%. The ex-dividend date of this dividend is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.

WARNING: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/papp-l-roy-associates-has-2039000-holdings-in-colgate-palmolive-company-cl/1604366.html.

In related news, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares of the company’s stock, valued at approximately $7,046,304.27. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the completion of the sale, the insider now directly owns 53,173 shares in the company, valued at approximately $3,799,210.85. The disclosure for this sale can be found here. Insiders sold a total of 217,969 shares of company stock valued at $15,693,933 over the last ninety days. Company insiders own 1.02% of the company’s stock.

CL has been the topic of a number of recent analyst reports. BidaskClub downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research report on Friday, June 30th. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research note on Tuesday, July 4th. Jefferies Group LLC boosted their target price on Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a research note on Thursday, July 6th. Finally, Deutsche Bank AG restated a “hold” rating and set a $75.00 target price on shares of Colgate-Palmolive in a research note on Monday, July 24th. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $76.31.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.